Panion & Bf BiotechTPE:1760 -1.37%73 OCF Yield % is 5.73 as of Jul. 08, 2026, which is 138% above its 10-year median of 2.41. GuruFocus rates TPE:1760 with a GF Score™ of 73/100 and a GF Value™ of NT$96.01 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Panion & Bf Biotech ranks better than 63.36% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Panion & Bf Biotech OCF Yield % Related Terms
Panion & Bf Biotech OCF Yield % Historical Data
* Premium members only.
The historical data trend for Panion & Bf Biotech's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1760 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Panion & Bf Biotech's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Panion & Bf Biotech OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Panion & Bf Biotech's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Panion & Bf Biotech's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Panion & Bf Biotech (TPE:1760) has a OCF Yield % of 5.73 as of Jul. 08, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Panion & Bf Biotech and its competitors. This is 138% above median its historical median of 2.41. According to the industry distribution chart, Panion & Bf Biotech ranks #369 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 36.6%.
Is Panion & Bf Biotech's OCF Yield % too high?
Panion & Bf Biotech's current OCF Yield % of 5.73 is 138% above median its 10-year median of 2.41. The Drug Manufacturers industry median OCF Yield % is 3.53. Panion & Bf Biotech's value of 5.73 is 62.3% above this industry median. Based on the distribution chart, Panion & Bf Biotech ranks #369 out of 1007 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Panion & Bf Biotech has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Panion & Bf Biotech's OCF Yield % compare to VRTX and REGN?
According to the Drug Manufacturers industry distribution chart, Panion & Bf Biotech ranks #369 out of 1007 companies for OCF Yield %. This puts Panion & Bf Biotech in the upper half of its industry. The industry median OCF Yield % is 3.53. Panion & Bf Biotech's value of 5.73 is 62.3% above this benchmark. While the company's 10-year median is 2.41 vs. the industry median of 3.53, Panion & Bf Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.53, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Panion & Bf Biotech's current OCF Yield % of 5.73 is 62.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Panion & Bf Biotech and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Panion & Bf Biotech's current OCF Yield % is 5.73, which is 138% above median its own 10-year median of 2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panion & Bf Biotech stock overvalued right now?
Based on GuruFocus' analysis, Panion & Bf Biotech (TPE:1760) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$96.01, compared to a current price of NT$65.00 — trading 32.3% below its estimated fair value. The current OCF Yield % is 5.73, which is 138% above median its 10-year median of 2.41 and 62.3% above the Drug Manufacturers industry median of 3.53. Panion & Bf Biotech's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Panion & Bf Biotech (TPE:1760), the current OCF Yield % is 5.73 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Panion & Bf Biotech (TPE:1760) Overvalued in 2026?
Based on GuruFocus' analysis, Panion & Bf Biotech stock appears to be undervalued.
The current stock price of NT$65.00 is trading 32.3% below its estimated GF Value™ of NT$96.01.
GuruFocus considers Panion & Bf Biotech to be Significantly Undervalued.
Key valuation signals for TPE:1760:
OCF Yield %: 5.73 (138% above median its 10-year median of 2.41)
GF Value™: NT$96.01 vs. price of NT$65.00 (32.3% below fair value)
Industry Position: 62.3% above the Drug Manufacturers median (#369 of 1007)
No single metric tells the full story. See the TPE:1760 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. The company, along with its subsidiaries, is mainly engaged in the manufacture and sales of pharmaceutical, cosmeceutical, diagnostic, medical device, and active pharmaceutical ingredients. It has four core business groups: disease treatment, disease prevention, disease diagnosis, and delayed aging. It has geographic segments in Taiwan; China, Hong Kong, and Macau; the USA; and Korea. It generates a majority of its revenue from the Taiwan segment. Product-wise the firm generates the majority of its revenue from Pharmaceutical products.
73GF Score
Get the complete analysis for TPE:1760
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1760 has been successfully added to your 
